Kindstar Globalgene Technology, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Chaoju Eye Care Holdings Ltd.

EC Healthcare

Perfect Medical Health Management Ltd.

Town Health International Medical Group Ltd.

EuroEyes International Eye Clinic Ltd.

MedSci Healthcare Holdings Ltd.

Arrail Group Ltd.

ClouDr Group Ltd.

Kindstar Globalgene Technology, Inc.

Yonghe Medical Group Co., Ltd.

Mega Genomics Ltd.

Why is Kindstar Globalgene Technology, Inc. ?

Weak Long Term Fundamental Strength with a -221.42% CAGR growth in Operating Profits over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of -9.14 times

Negative results in Jun 25

INTEREST(HY) At HKD 8.27 MM has Grown at 63.11%
PRE-TAX PROFIT(Q) At HKD -22.05 MM has Fallen at -234.66%
NET PROFIT(Q) At HKD -27.85 MM has Fallen at -315.47%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -16.67%, its profits have fallen by -291%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -16.67% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kindstar Globalgene Technology, Inc. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Kindstar Globalgene Technology, Inc.

-100.0%

-0.79

36.90%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

1.30%

EBIT Growth (5y)

-221.42%

EBIT to Interest (avg)

4.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.43

Sales to Capital Employed (avg)

0.36

Tax Ratio

8.05%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.06%

ROE (avg)

1.39%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.52

EV to EBIT

-1.88

EV to EBITDA

-4.67

EV to Capital Employed

0.15

EV to Sales

0.25

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.93%

ROE (Latest)

-1.47%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

NET PROFIT(HY)

Higher at HKD -27.85 MM

-15What is not working for the Company

INTEREST(HY)

At HKD 8.27 MM has Grown at 63.11%

PRE-TAX PROFIT(Q)

At HKD -22.05 MM has Fallen at -234.66%

NET PROFIT(Q)

At HKD -27.85 MM has Fallen at -315.47%

ROCE(HY)

Lowest at -3.59%

RAW MATERIAL COST(Y)

Grown by 13.38% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -38.7 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 8.87 times

NET SALES(Q)

Lowest at HKD 490.8 MM

Here's what is working for Kindstar Globalgene Technology, Inc.

Depreciation

Highest at HKD 58.28 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 58.28 MM has Grown at 39.41%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Kindstar Globalgene Technology, Inc.

Pre-Tax Profit

At HKD -22.05 MM has Fallen at -234.66%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (HKD MM)

Net Profit

At HKD -27.85 MM has Fallen at -315.47%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (HKD MM)

Interest

At HKD 8.27 MM has Grown at 63.11%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Net Sales

Lowest at HKD 490.8 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (HKD MM)

Debt-Equity Ratio

Highest at -38.7 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 8.87 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 13.38% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales